The Future Reimbursement Environment for NGS for Oncology

The Future Reimbursement Environment for NGS for Oncology

Charles Mathews, Vice President, Boston Healthcare
Topic: Cancer Genomics

Next-generation sequencing (NGS) is providing new tools to that are aimed at developing products to comprehensively profile cancer samples. However, as with any truly novel technology, payers likely will question the clinical utility of NGS and scrutinize testing coverage. Join us to hear Charles Mathews, Vice President of Boston Healthcare, review how reimbursement is likely to play out in the future for key applications of NGS technology in the oncology space. 



There are no related events.